Petri M, Bruce IN, Dorner T, Tanaka Y, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet 2023 Feb 24:S0140-6736(22)02546-6. doi: 10.1016/S0140-6736(22)02546.
PMID: 36848919